"Heparin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
| Descriptor ID |
D006493
|
| MeSH Number(s) |
D09.698.373.400
|
| Concept/Terms |
Heparin- Heparin
- Unfractionated Heparin
- Heparin, Unfractionated
- Heparinic Acid
|
Below are MeSH descriptors whose meaning is more general than "Heparin".
Below are MeSH descriptors whose meaning is more specific than "Heparin".
This graph shows the total number of publications written about "Heparin" by people in this website by year, and whether "Heparin" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 9 | 12 |
| 1996 | 9 | 8 | 17 |
| 1997 | 10 | 10 | 20 |
| 1998 | 9 | 14 | 23 |
| 1999 | 10 | 8 | 18 |
| 2000 | 8 | 10 | 18 |
| 2001 | 9 | 13 | 22 |
| 2002 | 15 | 13 | 28 |
| 2003 | 14 | 10 | 24 |
| 2004 | 15 | 14 | 29 |
| 2005 | 16 | 11 | 27 |
| 2006 | 7 | 16 | 23 |
| 2007 | 10 | 12 | 22 |
| 2008 | 13 | 20 | 33 |
| 2009 | 7 | 11 | 18 |
| 2010 | 9 | 12 | 21 |
| 2011 | 10 | 12 | 22 |
| 2012 | 8 | 11 | 19 |
| 2013 | 12 | 5 | 17 |
| 2014 | 11 | 7 | 18 |
| 2015 | 8 | 7 | 15 |
| 2016 | 8 | 8 | 16 |
| 2017 | 14 | 6 | 20 |
| 2018 | 12 | 3 | 15 |
| 2019 | 11 | 8 | 19 |
| 2020 | 8 | 11 | 19 |
| 2021 | 13 | 10 | 23 |
| 2022 | 5 | 9 | 14 |
| 2023 | 1 | 18 | 19 |
| 2024 | 2 | 4 | 6 |
| 2025 | 1 | 0 | 1 |
Below are the most recent publications written about "Heparin" by people in Profiles.
-
TEG® 6s coagulation testing with a novel heparin neutralization cartridge: Technical validation and determination of normal reference ranges. Am J Clin Pathol. 2025 Jan 28; 163(1):12-19.
-
Polyphenol-stabilized coacervates for enzyme-triggered drug delivery. Nat Commun. 2024 Aug 24; 15(1):7295.
-
Alteration of Neuropilin-1 and Heparan Sulfate Interaction Impairs Murine B16 Tumor Growth. ACS Chem Biol. 2024 Aug 16; 19(8):1820-1835.
-
Key considerations in navigating ticagrelor's reported effect on heparin-induced thrombocytopenia functional assays in a landscape of limited data. Am J Health Syst Pharm. 2024 Jun 11; 81(12):488-493.
-
A comparison of computational algorithms for the Bayesian analysis of clinical trials. Clin Trials. 2024 Dec; 21(6):689-700.
-
Prophylactic Unfractionated Heparin in Antepartum Hospitalizations: A Randomized Controlled Trial. Obstet Gynecol. 2024 Jul 01; 144(1):118-125.
-
Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: An EAST sponsored multicenter study. Injury. 2024 Sep; 55(9):111523.
-
Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States. Ren Fail. 2023; 45(2):2290932.
-
Risk-stratified thromboprophylaxis effects of aspirin versus low-molecular-weight heparin in orthopedic trauma patients: A secondary analysis of the PREVENT CLOT trial. J Trauma Acute Care Surg. 2024 Apr 01; 96(4):573-582.
-
An international RAND/UCLA expert panel to determine the optimal diagnosis and management of burn inhalation injury. Crit Care. 2023 11 27; 27(1):459.